NHS (Neuberger High Yield Strategies Fund Inc.) Stock Analysis - Politician Trades
Neuberger High Yield Strategies Fund Inc. (NHS) is a publicly traded Financial Services sector company. As of May 21, 2026, NHS trades at $6.25 with a market cap of $197.31M and a P/E ratio of 0.00. NHS moved +0.56% today. Year to date, NHS is -15.88%; over the trailing twelve months it is -16.56%. Its 52-week range spans $6.13 to $8.67. Rallies surfaces NHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded NHS stock?
Rallies tracks politician and congressional stock disclosures for NHS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Kocinski Chris bought 6.00K (~$44.40K) on Jul 17, 2025.
Kocinski Chris bought 15.00K (~$111.60K) on May 29, 2025.
Lind Joseph bought 5.00K (~$45.71K) on Jun 7, 2022.
NHS Analyst Consensus
NHS analyst coverage data. Average price target: $0.00.
Common questions about NHS
Which politicians traded NHS stock?
Rallies tracks politician and congressional stock disclosures for NHS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in NHS?
Yes. Rallies tracks politician and congressional stock disclosures for NHS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is NHS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHS. It does not provide personalized investment advice.
